Inhibitory effect of arsenic trioxide on neuronal migration in vitro and its potential molecular mechanism

Environmental Toxicology and Pharmacology

Volumn 40, Issue 3, 2015, Pages 671-677

  Zhou, Hao ^a   Liu, Ye ^a   Tan, Xin Jie ^a   Wang, Yu Chuan ^a   Liu, Kai Yu ^a   Cui, Yu Xia ^a  

^a GUIZHOU PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

Arsenic trioxide; Neuronal migration; Primary neuron culture

Indexed keywords

ARSENIC TRIOXIDE; BETA ACTIN; DOUBLECORTIN; GELATINASE A; GELATINASE B; RNA; DOUBLECORTIN PROTEIN; MICROTUBULE ASSOCIATED PROTEIN; MMP2 PROTEIN, RAT; MMP9 PROTEIN, RAT; NEUROPEPTIDE; ORGANOARSENIC DERIVATIVE; OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BRAIN CELL CULTURE; CELL MIGRATION; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; IN VITRO STUDY; MOLECULAR MECHANICS; MRNA EXPRESSION ASSAY; NERVE CELL CULTURE; NEWBORN; NONHUMAN; OPTICAL DENSITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; ANIMAL; CELL CULTURE; CELL MOTION; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NERVE CELL;

ANIMALS; ANIMALS, NEWBORN; ARSENICALS; CELL MOVEMENT; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION; IN VITRO TECHNIQUES; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; MICROTUBULE-ASSOCIATED PROTEINS; NEURONS; NEUROPEPTIDES; OXIDES; RATS;

EID: 84942093634     PISSN: 13826689     EISSN: 18727077     Source Type: Journal    
DOI: 10.1016/j.etap.2015.08.026     Document Type: Article

References (34)

1. Amigo-Jiménez I., Bailón E., Ugarte-Berzal E., Aguilera-Montilla N., García-Marco J.A., García-Pardo A. Matrix metalloproteinase-9 is involved in chronic lymphocytic leukemia cell response to fludarabine and arsenic trioxide. PLOS ONE 2014, 9:e99993. eCollection 2014. 10.1371/journal.pone.0099993.
2. Aung K.H., Kurihara R., Nakashima S., Maekawa F., Nohara K., Kobayashi T., Tsukahara S. Inhibition of neurite outgrowth and alteration of cytoskeletal gene expression by sodium arsenite. Neurotoxicology 2013, 34:226-235. 10.1016/j.neuro.2012.09.008.
3. Bruggemann D., Frohnmayer J.P., Spatz J.P. Model systems for studying cell adhesion and biomimetic actin networks. Beilstein J. Nanotechnol. 2014, 5:1193-1202.
4. Centeno J.A., Mullick F.G., Martinez L., Page N.P., Gibb H., Longfellow D., Thompson C., Ladich E.R. Pathology related to chronic arsenic exposure. Environ. Health Perspect. 2002, 110(Suppl. 5):883.
5. Chang Y.W., Chen M.W., Chiu C.F., Hong C.C., Cheng C.C., Hsiao M., Chen C.A., Wei L.H., Su J.L. Arsenic trioxide inhibits CXCR4-mediated metastasis by interfering miR-520h/PP2A/NF-κB signaling in cervical cancer. Ann. Surg. Oncol. 2014, (Suppl. 4):S687-S695. 10.1245/s10434-014-3812-5.
6. Cheung W.M., Chu P.W., Kwong Y.L. Effects of arsenic trioxide on the cellular proliferation, apoptosis and differentiation of human neuroblastoma cells. Cancer Lett. 2007, 246(1-2):122-128.
7. Ding X., Su Q., Jiang M., Xie H., Cong J., Wang L. Arsenic affects on cerebellar development of mice. Toxicol. Mech. Methods 2013, 23:672-677. 10.3109/15376516.2013.840347.
8. Frankel S., Concannon J., Brusky K., Pietrowicz E., Giorgianni S., Thompson W.D., Currie D.A. Arsenic exposure disrupts neurite growth and complexity in vitro. Neurotoxicology 2009, 30:529-537.
9. Galliera E., Tacchini L., Romanelli M.M. Matrix metalloproteinases as biomarkers of disease: updates and new insights. Clin. Chem. Lab. Med. 2015, 53(3):349-355. 10.1515/cclm-2014-0520.
10. Guha Mazumder D., Dasgupta U.B. Chronic arsenic toxicity: studies in West Bengal, India. Kaohsiung J. Med. Sci. 2011, 27:360-370.
11. Hall A.H. Chronic arsenic poisoning. Toxicol. Lett. 2002, 128:69-72.
12. Igarashi A., Kawatani M., Ohta G., Kometani H., Ohshima Y., Kato M. A male case of subcortical band heterotopia with somatic mosaicism of DCX mutation. No To Hattatsu 2013, 45:371-374. (in Japanese).
13. Jomova K., Jenisova Z., Feszterova M., Baros S., Liska J., Hudecova D., Rhodes C.J., Valko M. Arsenic: toxicity, oxidative stress and human disease. J. Appl. Toxicol. 2011, 31:95-107.
14. Katiyar S., Singh D. Prevalence of arsenic exposure in population of Ballia district from drinking water and its correlation with blood arsenic level. J. Environ. Biol. 2014, 35:589-594.
15. Liu J.S. Molecular genetics of neuronal migration disorders. Curr. Neurol. Neurosci. Rep. 2011, 1:171-178.
16. Liu G., Wang P., Li X., Li Y., Xu S., Uéda K., Chan P., Yu S. Alpha-synuclein promotes early neurite outgrowth in cultured primary neurons. J. Neural Transm. 2013, 120:1331-1343.
17. Luo J., Qiu Z.Q., Shu W.Q., Zhang Y.Y., Zhang L., Chen J.A. Effects of arsenic exposure from drinking water on spatial memory, ultra-structures and NMDAR gene expression of hippocampus in rats. Toxicol. Lett. 2009, 184:121-125.
18. Mandal B.K., Suzuki K.T. Arsenic round the world: a review. Talanta 2002, 58:201-235.
19. Mathew L., Vale A., Adcock J.E. Arsenical peripheral neuropathy. Pract. Neurol. 2010, 10:34-38.
20. Melleu F., Santos T.S., Lino-de-Oliveira C., Marino-Neto J. Distribution and characterization of doublecortin-expressing cells and fibers in the brain of the adult pigeon (Columba livia). J. Chem. Neuroanat. 2013, 47:57-70.
21. Moon H.M., Wynshaw-Boris A. Cytoskeleton in action: lissencephaly, a neuronal migration disorder. Wiley Interdiscip. Rev. Dev. Biol. 2013, 2:229-245.
22. Moores C.A., Perderiset M., Francis F., Chelly J., Houdusse A., Milligan R.A. Mechanism of microtubule stabilization by doublecortin. Mol. Cell 2004, 14:833-839.
23. Nishimura Y.V., Shikanai M., Hoshino M., Ohshima T., Nabeshima Y., Mizutani K., Nagata K., Nakajima K., Kawauchi T. Cdk5 and its substrates, Dcx and p27kip1, regulate cytoplasmic dilation formation and nuclear elongation in migrating neurons. Development 2014, 141:3540-3550. 10.1242/dev.111294.
24. Ould-Yahoui A., Sbai O., Baranger K., Bernard A., Gueye Y., Charrat E., Clément B., Gigmes D., Dive V., Girard S.D., Féron F., Khrestchatisky M., Rivera S. Role of matrix metalloproteinases in migration and neurotrophic properties of nasal olfactory stem and ensheathing cells. Cell Transplant. 2013, 22:993-1010. 10.3727/096368912X657468.
25. Piao F., Ma N., Hiraku Y., Murata M., Oikawa S., Cheng F., Zhong L., Yamauchi T., Kawanishi S., Yokoyama K. Oxidative DNA damage in relation to neurotoxicity in the brain of mice exposed to arsenic at environmentally relevant levels. J. Occup. Health 2005, 47:445-449.
26. Pratt M., Wadden P., Gulliver W. Arsenic keratosis in a patient from Newfoundland and Labrador, Canada: case report and review. J. Cutan. Med. Surg. 2015, pii: 1203475415599342.
27. Ravenscroft P., Brammer H., Richards K. Arsenic Pollution: A Global Synthesis 2009, vol. 28:589. Wiley-Blackwell, Oxford, (RGS-IBG Book Series).
28. Saha J.C., Dikshit A.K., Bandyopadhyay M., Saha K.C. A review of arsenic poisoning and its effects on human health. Crit. Rev. Environ. Sci. Technol. 1999, 29:281-313.
29. Sun G. Arsenic contamination and arsenicosis in China. Toxicol. Appl. Pharmacol. 2004, 198:268-271.
30. Valiente M., Marín O. Neuronal migration mechanisms in development and disease. Curr. Opin. Neurobiol. 2010, 20:68-78.
31. Xiao J., Zhang M., Pan Y., Yang Q., Zhang J.J., Chen T.X., Wang X.D., Yi B.D. Chronic arsenic exposed effect on the learning and memory function of rat. Chin. J. Med. Phys. 2006, 2:010.
32. Yen C.C., Ho T.J., Wu C.C., Chang C.F., Su C.C., Chen Y.W., Jinn T.R., Lu T.H., Cheng P.W., Su Y.C., Liu S.H., Huang C.F. Inorganic arsenic causes cell apoptosis in mouse cerebrum through an oxidative stress-regulated signaling pathway. Arch. Toxicol. 2011, 85:565-575. 10.1007/s00204-011-0709-y.
33. Zhao F., Liao Y., Jin Y., Li G., Lv X., Sun G. Effects of arsenite on glutamate metabolism in primary cultured astrocytes. Toxicol. In Vitro 2012, 26:24-31.
34. Zheng W. Toxicology of choroid plexus: special reference to metal-induced neurotoxicities. Microsc. Res. Tech. 2001, 52:89-103.